Advanced Options for Ovarian Cancer Treatment
August 7, 2015
New Patient Appointment Accepting Virtual Visits or 214-645-8300
David Scott Miller, M.D., is a Professor in the Department of Obstetrics and Gynecology at UT Southwestern Medical Center. He specializes in cancers of the female reproductive system and serves as chief of the Division of Gynecologic Oncology, leading the team of gynecologic oncologists at UT Southwestern. In addition, he is Medical Director for the division’s practice at the Harold C. Simmons Comprehensive Cancer Center and Medical Director for gynecologic oncology at Parkland Health and Hospital System.
Dr. Miller earned his medical degree at the University of Oklahoma–Tulsa and completed a residency in obstetrics and gynecology at the Medical College of Pennsylvania. He received advanced training through a reproductive endocrinology fellowship at the University of California, San Diego and a gynecologic oncology fellowship at Stanford University Medical Center.
Board certified in obstetrics and gynecology and gynecologic oncology, he joined the UT Southwestern faculty in 1991.
Dr. Miller serves as principal investigator for the National Cancer Institute’s Gynecologic Oncology Group program at UT Southwestern. He also is an examiner for the American Board of Obstetrics and Gynecology, where he participates in the oral examination of physicians seeking certification as specialists in gynecologic oncology.
Dr. Miller’s research interests include reconstructive pelvic surgery, gynecologic oncology, and clinical trials. He has published several academic articles.
He is frequently included in D Magazine’s list of Best Doctors in Dallas and as a Super Doctor in Texas Monthly magazine.
Dr. Miller is a member of the Society of Gynecologic Oncology, the American Society of Clinical Oncology, the American College of Obstetricians and Gynecologists, and the American College of Surgeons.
Early in his career, David Scott Miller, M.D., decided that his mission was helping women with their journey through cancer. He believes that no matter what the cancer diagnosis is, it brings a sense of urgency and clarity. That belief is part of the driving force behind his nationally and internationally recognized work to improve the evaluation and treatment of gynecologic cancers.
"When and where the cancer is diagnosed will have an impact on a woman’s chances of surviving the disease. It’s extremely important to have one doctor trained in all aspects of evaluating and treating gynecologic cancer committed to the patient," he says.
Since joining UT Southwestern Medical Center in 1991, Dr. Miller has assembled a team focused completely on gynecologic cancers. This team includes faculty physicians – trained and board certified in obstetrics and gynecology – who have gone on to complete fellowship training in gynecologic oncology. They are experts in gynecology and the cancers that affect the female reproductive organs and are passionate about caring for women with gynecologic cancer.
Cancers affecting a woman’s reproductive system, including the ovaries, uterus, cervix, vagina, vulva, and placenta, can be complex. Dr. Miller and his team bring a comprehensive approach to care that offers patients unique access to the newest diagnostic procedures, innovative therapies and surgical care, exceptional support services, and groundbreaking research and clinical trials.
An advocate of providing the newest options to patients, Dr. Miller says UT Southwestern is on the leading edge of surgical and medical innovations to eliminate gynecologic cancer. These innovations include state-of-the-art minimally invasive and robotic procedures to remove tumors, fertility-sparing procedures, and targeted therapies to attack cancer cells without damaging noncancerous tissue.
Dr. Miller serves as a principal investigator for the National Cancer Institute’s Gynecologic Oncology Group and participates in the cancer evaluation and treatment protocols developed by that organization. UT Southwestern is also the only institution in North Texas that is a member of the National Institutes of Health’s (NIH) Gynecologic Oncology Group, which is the hub of major research and innovations for gynecologic cancers.
Results: 1 Locations